Developmental Therapeutics

4 currently open clinical trials

A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors

SAKK 65/16

Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)

SAKK 69/17

Therapy with docetaxel micellar in metastatic, castration-resistant prostate cancer

SAKK 67/20

Thermal ablation (radio frequency ablation) and intratumoral injection of IP-001 in advanced solid tumor patients

SAKK IP-IIO-622_SAKK 69/22

All cancer types